Skip to main content

Department of Medicine

Probing H. pylori cancer protein

Feb. 15, 2019—Timothy Cover, john Loh and colleagues have identified how a certain type of mutation influences the risk of premalignant and malignant changes in the stomach.

Read more


New target for chronic kidney disease

Jan. 31, 2019—Craig Brooks and colleagues have identified a mechanism of kidney fibrosis progression, suggesting a potential new angle for treating chronic kidney disease.

Read more


In utero antibiotics and obesity risk

Jan. 31, 2019—Exposure to antibiotics during pregnancy does not raise the risk of obesity in children.

Read more


School for Science and Math students place in national competition

Jan. 9, 2019—Three members of the School for Science and Math at Vanderbilt’s senior class are semifinalists in the Regeneron Science Talent Search.

Read more


Lindsley named fellow of National Academy of Inventors

Jan. 4, 2019—Craig Lindsley, co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been named a fellow of the National Academy of Inventors.

Read more


Philip’s liver cancer research receives V Foundation support

Dec. 13, 2018—The grant will support Mary Philip's research to develop an organoid model — a miniature cell model of a functioning organ — of the liver to enable three-dimensional observation of immune-cancer interactions at the single-cell level at the earliest stages of cancer development.

Read more


Immunotherapies linked to specific heart complications

Nov. 16, 2018—In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have identified several of the conditions that arise and have determined that they usually appear early in treatment.

Read more


Probing the pathology of impaired cognition

Oct. 26, 2018—A new link between a support protein within the brain's white matter and known Alzheimer's biomarkers discovered by Angela Jefferson and colleagues bring researchers a step toward earlier and more precise detection of neuropathology underlying cognitive impairment that may lead to new targeted therapies

Read more


Novel genetic study sheds new light on risk of heart attack

Oct. 11, 2018—Loss of a protein that regulates mitochondrial function can greatly increase the risk of a heart attack, report Eric Gamazon, Sandra Zinkel and graduate students Christie Salisbury-Ruf and Clinton Bertram in new research.

Read more


Stretch, inflammation and hypertension

Oct. 4, 2018—New research by David Harrison and colleagues sheds light on how changes in mechanical forces in the aorta enhance immune cell activation thus promoting hypertension.

Read more


Study reveals new targets to inhibit pulmonary fibrosis

Oct. 4, 2018—An international team led by researchers at Vanderbilt University Medical Center sheds new light on the cause of pulmonary fibrosis and demonstrates a way to impede the disease.

Read more


Cancer Moonshot award to help map tumor progression

Sep. 27, 2018—A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

Read more


Upcoming Events

MORE EVENTS »